. Binding of glVRC01-class antibodies to 426c Env with mutations previously identified as improving antibody-recognition of the outer domain of gp120, eOD-GT6. The interaction of the indicated gl antibodies to gp120 variants of 426cTM1 with six additional mutations identified to improve glVRC01-class antibodies to eOD-GT6 12 were determined by BLI. BLI traces are representative of at least 3 independent replicates.
Supplementary Figure 3. Effect of Env variable loop deletions on the binding of gl3BNC60.
Binding of gl3BNC60 to 426cTM4 gp120, or to 426cTM4 gp120 with the variable regions 1, 2 and 3 deleted individually (426cTM4ΔV1, 426cTM4ΔV2 and 426cTM4ΔV3, respectively), or in combination (426cTM4ΔV1/2 and 426cTM4ΔV1-3). BLI traces are representative of 2 independent replicates.
Supplementary Figure 4. Antibody responses elicited in WT and knock-in gl3BNC60 mice after immunization.
(a)Serum IgG collected prior to (naïve) and following one or two immunizations (post 1, 2) with 426cTM4ΔV1-V3 gp140 in Alum Imject were tested for binding to 426cTM4ΔV1-V3 gp140 (solid lines) or 426cTM4ΔV1-V3.gp140.D368R.E370A protein (KO) (dotted lines) in WT (left three panels, n=3) and knock-in gl3BNC60 mice (right three panels, n=3) by ELISA. Colors indicate individual mice. (b) Same as in a but WT mice (n=5, left panel) or gl3BNC60 KI (n=5, right panel) mice were immunized once with 426cTM4ΔV1-V3 gp140 dextramer in Alum Imject. (c) Same as in a but WT (n=5, left panel) or gl3BNC60 KI mice (n=5, middle panel) were immunized once with 426cTM4ΔV1-V3 gp120-dextramers in Alum Imject, or in Ribi adjuvant (n=5, right panel). (d) Same as in a but gl3BNC60 KI mice (n=5) were immunized once with 426c.TM4ΔV1-V3 gp120-C4b in Ribi adjuvant. (e) Same as in a but WT mice (n=3, left panel) or gl3BNC60 KI mice (n=5, right panel) were immunized once with 426cTM4ΔV1-V3 gp120-ferritin in Alum Imject. The red and orange lines correspond to the serum responses of the mice that were used for sorting in Figs.4, S6 and Table S3 . (f) Serum IgG from WT (n=4)and 3BNC60 KI mice (n=5) after one (p1, left two panels) or two (p2, right two panels) immunizations with WT 426c gp140-dextramer in Alum Imject were tested for binding to WT 426c gp140 (solid lines) or 426c.D368R.E370A (426c-KO, dotted lines) by ELISA. (g) gl3BNC60 (red curves), mut3BNC60 (green curves) and polyclonal HIV-IgG reagent (blue curves) were tested for binding to 426cTM4ΔV1-V3 (left panel) or 426cTM4ΔV1-V3-KO (right panel).
Supplementary Figure 5. Biochemical characterization of 426cTM4∆V1-3 multimers.
(a) Chromatograms of the indicated multimeric 426cTM4ΔV1-3 variants run on a 10/300 Superose 6 column. The elution volume is indicated above the peak of each trace. (b) 10 µg of the indicated multimeric 426cTM4ΔV1-3 variants were subjected to BN-PAGE. 
